TY - JOUR
T1 - Attenuation of pharmacological effects and increased metabolism of phencyclidine in morphine tolerant mice
AU - Nabeshima, Toshitaka
AU - Sivam, Subbiah P.
AU - Ho, Ing K.
N1 - Funding Information:
The excellent technical assistance of Ms. C.M. Reese and Mrs. Noriko Nabeshima was greatly appreciated. This work was supported by a grant (DA-01310) from the National Institute on Drug Abuse.
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1984/9/17
Y1 - 1984/9/17
N2 - Mice were used for a study of the interaction between morphine and phencyclidine (PCP) in relation to lethality, motor incoordination, locomotor activity and rearing, together with the half-life of PCP, following continuous administration of morphine by pellet (75 mg base) implantation for 72 h and after removal of the pellets for 6 and 24 h. PCP induced motor incoordination and suppressed locomotor activity and rearing; these effects were enhanced in morphine 'pellet-implanted' mice and were attenuated in morphine 'pellet-removed' groups. The enhancing effect of morphine on the PCP responses was attributable more to the presence of residual morphine than to the alterations in its disposition. The morphine-induced increase in locomotor activity and analgesia was attenuated in PCP (40 mg/kg per day i.p. for 5 days) tolerant mice. The rate of decay of PCP in serum and brain or morphine pellet-implanted animals was not different; however, in the 24 h 'pellet-removed' group, the rate of decay of PCP was increased. The results indicate that there is a two-way cross-tolerance development between PCP and morphine. The phenomenon appears to involve both dispositional and functional adaptation mechanisms.
AB - Mice were used for a study of the interaction between morphine and phencyclidine (PCP) in relation to lethality, motor incoordination, locomotor activity and rearing, together with the half-life of PCP, following continuous administration of morphine by pellet (75 mg base) implantation for 72 h and after removal of the pellets for 6 and 24 h. PCP induced motor incoordination and suppressed locomotor activity and rearing; these effects were enhanced in morphine 'pellet-implanted' mice and were attenuated in morphine 'pellet-removed' groups. The enhancing effect of morphine on the PCP responses was attributable more to the presence of residual morphine than to the alterations in its disposition. The morphine-induced increase in locomotor activity and analgesia was attenuated in PCP (40 mg/kg per day i.p. for 5 days) tolerant mice. The rate of decay of PCP in serum and brain or morphine pellet-implanted animals was not different; however, in the 24 h 'pellet-removed' group, the rate of decay of PCP was increased. The results indicate that there is a two-way cross-tolerance development between PCP and morphine. The phenomenon appears to involve both dispositional and functional adaptation mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=0021164241&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021164241&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(84)90396-0
DO - 10.1016/0014-2999(84)90396-0
M3 - Article
C2 - 6499921
AN - SCOPUS:0021164241
SN - 0014-2999
VL - 104
SP - 211
EP - 221
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 3-4
ER -